Gainers
- Silexion Therapeutics (NASDAQ:SLXN) stock rose 11.8% to $1.61 during Wednesday's after-market session. The market value of their outstanding shares is at $1.0 million. As per the news, the Q3 earnings report came out 4 days ago.
- Actuate Therapeutics (NASDAQ:ACTU) shares increased by 11.03% to $0.27. The market value of their outstanding shares is at $6.0 million. As per the news, the Q3 earnings report came out 3 days ago.
- ImageneBio (NASDAQ:IMA) stock moved upwards by 9.71% to $4.18. The market value of their outstanding shares is at $44.2 million.
- Instinct Bio Technical Co (NASDAQ:BIOT) shares rose 8.93% to $0.2. The market value of their outstanding shares is at $5.2 million.
- IM Cannabis (NASDAQ:IMCC) shares moved upwards by 8.25% to $0.58. As per the news, the Q3 earnings report came out 3 days ago.
- Kardigan (NASDAQ:KARD) shares rose 5.51% to $13.0. The market value of their outstanding shares is at $1.2 billion. The company's, Q3 earnings came out 4 days ago.
Losers
- DarioHealth (NASDAQ:DRIO) stock fell 8.2% to $1.34 during Wednesday's after-market session. The company's market cap stands at $12.9 million. The company's, Q3 earnings came out 4 days ago.
- Beyond Air (NASDAQ:XAIR) shares decreased by 5.41% to $1.75. The market value of their outstanding shares is at $3.3 million.
- OS Therapies (AMEX:OSTX) stock declined by 5.2% to $0.87. The company's market cap stands at $38.9 million.
- SeaStar Medical Holding (NASDAQ:ICU) shares declined by 4.81% to $0.99. The company's market cap stands at $4.1 million.
- Lakewood-Amedex (NASDAQ:LABT) shares declined by 4.17% to $0.23. The company's, Q3 earnings came out 2 days ago.
- Curis (NASDAQ:CRIS) shares fell 4.17% to $0.59. The company's market cap stands at $1.3 million. As per the press release, Q3 earnings came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Share this article


